We have compiled a playlist from all our shows and podcasts on our network that discuss the current COVID-19 pandemic.
Products and Technology
Connect Up Technologies Introduces SafeDistance Contact Tracing Solution
With the COVID-19 pandemic raging through the US and many countries across the globe, safety technology company, Connect Up Technologies (@connectup_tech), announces the immediate availability of the SafeDistance Contact Tracing solution.
Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
Parexel (@Parexel), a provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, announced that its Biotech division has entered into a strategic collaboration with Synairgen plc, a respiratory drug discovery and development company, to conduct a pivotal phase III study of an interferon beta (IFN-beta) treatment for patients hospitalized with COVID-19.
COVID-19 Weekly Insights from hc1
Follow this weekly dashboard for COVID-19 weekly insights driven by the CV19 Lab Testing Dashboard powered by hc1 (@hc1dotcom) and a coalition of laboratories at no charge to public health officials, government agencies, and healthcare providers.
T.H.E.M. Establishes the New Standard in COVID-19 Testing and Management
The Health Exchange Market (T.H.E.M.), Nashville, TN, introduces the first COVID-19 Remote Patient Monitoring (“RPM”) solution that supports physicians management of high-risk patients throughout the infection state. T.H.E.M.s novel platform is integrated with the newly released CLIA waived POC IgG/IgM Rapid Antibody test, providing a physician, for the first time, the ability to both administer a test and be reimbursed by Medicare and other commercial insurances.
Apollo Medco To Introduce One of the Healthcare Industry’s Most Accurate, Reliable and Quickest COVID-19 Testing Platforms for Businesses, Organizations, Municipalities and Individuals
Apollo Medco (@ApolloMedco), a medical technology solutions company, announced the planned availability of its new rapid lateral flow antigen COVID-19 testing platform starting in November 2020. The “COVID CleanPass by Apollo Medco” system is a mobile app-linked, HIPAA compliant, cloud secure and data-backed COVID-19 testing platform which gives testers the ability to process an unprecedented 200-300 people each hour and report results within 15 minutes utilizing testing kits from Quidel, BD and Abbott.
The Doc Announces New Rapid Detection SARS-CoV-2 Antibody Test Kit, Plans to Alleviate COVID-19 Testing Delays
The Doc, LLC. announced the development of a new rapid detection serological antibody test kit for SARS-CoV-2, the virus that causes COVID-19. With results in minutes using only a drop of blood, the Company’s IgM/IgG antibody test has been submitted for Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). The Company has already conducted several rounds of clinical trials with patients in Los Angeles, using antibody testing as an accurate and reliable diagnostic tool.
FDA Approves First Treatment for COVID-19
The U.S. Food and Drug Administration (@US_FDA) approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval.
QuVa Pharma® Announces Availability of Intravenous Dexamethasone to Support Hospitalized COVID-19 Patients
QuVa Pharma, Inc. confirms its ability to provide Dexamethasone Phosphate as a compounded sterile product in a ready-to-administer IV bag, under FDA Drug Shortage guidelines. QuVa Pharma’s Dexamethasone Phosphate is a compounded sterile product (CSP) available as 6 mg in 25 ml 0.9% sodium chloride IV bag and is now available to be ordered.
News and Noted
CT Defense Launches U.S. Operations, Offering Turn-Key, Mobile Hospital & Military Solutions to Rapidly Deploy During Natural & Manmade Disasters
CT Defense (@ct_defense), a global mobile infrastructure manufacturer, announced the launch of its U.S. operations following a successful deployment with Florida’s Division of Emergency Management at Winter Haven Hospital to combat the ongoing COVID-19 pandemic. As a provider of mobile hospital systems and military support units, the announcement solidifies CT Defense’s global expansion strategy.
FDA Vaccine Approval Committee Fails to Solicit Public Input Despite Widespread Concerns
According to recent surveys, nearly 50% of Americans say they are unlikely to get a COVID-19 vaccine when it becomes available. The main reasons cited are concerns about potential negative side effects and a lack of trust and transparency in the approval process.
COVID-19 vs. INFLUENZA (FLU) symptoms: How can you tell the difference? by Amery Free Press – You’ve probably aware that COVID and influenza share many of the same symptoms. You might even be feeling a little under the weather now. So, how do you tell the difference between COVID symptoms and flu symptoms? The short answer is: It can be tricky.
Survey: Three-Fourths of Hospital Executives Concerned About Financial Viability Without Effective COVID-19 Treatment or Vaccine by Kaufman Hall (@KaufmanHall) – Nearly three-quarters of hospital leaders are either moderately (52%) or extremely (22%) concerned about the financial viability of their organizations without an effective treatment or vaccine for COVID-19, according to a new report from Kaufman Hall. One-third of respondents (33%) saw operating margin declines in excess of 100% in the second quarter of 2020 compared with the same period of 2019.
Supplyframe Study of Medical Devices Supply Chain Indicates U.S. Will Have the Right Equipment to Create, Distribute COVID-19 Vaccine at Scale Within a Year by MPO Magazine (@mpomagazine) – New research from Supplyframe indicates that nearly a third (32 percent) of supply chain professionals believe it will take six to 12 months for the global supply chain to be back at full capacity following the disruptions due to the pandemic, and a fifth (20 percent) said it will take 12 months to 2 years. Yet the same research shows that 66 percent think that if a vaccine is approved for use in the U.S., the necessary medical equipment will be available to produce and distribute that vaccine at scale within one year.
Latest from HHS:
Trump Administration Takes Action to Further Expand Access to Vaccines, COVID-19 Tests
Trump Administration Makes Major Investment to Increase Availability of Fast Molecular POC Test
Trump Administration Expands Manufacturing Capacity with Cytiva for Components of COVID-19 Vaccines
Trump Administration Partners with CVS and Walgreens to Provide COVID-19 Vaccine to Protect Vulnerable Americans in Long-Term Care Facilities Nationwide
Trump Administration Provides Saliva Test at Surge Testing Site in Waco, TX
Physicians’ Reciprocal Insurers (PRI)
What: COVID-19 Physician Peer Support
When: Mondays 8:00 p ET; Tuesdays & Thursdays 5:30 – 6:30 pm ET
Register for Monday Groups
Register for Tuesday & Thursday Groups
COVID-19 Physician Peer Support – PRI has multiple weekly complimentary Virtual Support Groups on Coping with COVID-19 which your fellow physicians have been utilizing and finding great comfort and support from.
HealthcareNOW Radio rounded up some health IT resources being offered by companies to help healthcare professionals, American citizens and all of those affected in the fight against the coronavirus.
CDC is one of the major operating components of the Department of Health and Human Services. CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the US. CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats.
Health Center COVID-19 Testing
Updated weekly using data from the Health Center COVID-19 Survey, the Health Center COVID-19 Testing Dashboard provides a high-level view of total COVID-19 tests conducted and the distribution of positive COVID-19 tests by race and ethnicity.